These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34367284)

  • 41. Molecular clustering based on gene set expression and its relationship with prognosis in patients with lung adenocarcinoma.
    Xing B; Shi L; Bao Z; Liang Y; Liu B; Liu R
    J Thorac Dis; 2022 May; 14(5):1638-1650. PubMed ID: 35693605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma.
    Kuang J; Zheng Z; Ma W; Zeng S; Wu D; Weng X; Chen Y
    Front Pharmacol; 2023; 14():1240736. PubMed ID: 37781711
    [No Abstract]   [Full Text] [Related]  

  • 43. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
    Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
    J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.
    Sun G; Wang T; Shi M; Zhou H; Wang J; Huang Z; Zhang H; Shi J
    Ann Transl Med; 2021 Jul; 9(13):1057. PubMed ID: 34422969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 49. Construction of immune cell infiltration score model to assess prognostic ability of tumor immune environment in lung adenocarcinoma.
    Tian J; Fu C; Peng Q; Yang J; Fan X; Zeng X; Qing W; Wu Y
    Am J Transl Res; 2023; 15(3):1730-1743. PubMed ID: 37056847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
    Wen Y; Lin A; Zhu W; Wei T; Luo P; Guo L; Zhang J
    Front Pharmacol; 2021; 12():645862. PubMed ID: 34163353
    [No Abstract]   [Full Text] [Related]  

  • 53. Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures.
    Huo C; Zhang MY; Li R; Liu TT; Li JP; Qu YQ
    Front Cell Dev Biol; 2021; 9():645482. PubMed ID: 34368114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma.
    Li J; Li H; Zhang C; Zhang C; Jiang L; Wang H; Liu H
    Front Oncol; 2021; 11():732841. PubMed ID: 34631565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ceramide Pathway Regulators Predict Clinical Prognostic Risk and Affect the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Zhang Y; Chen J; Zhao Y; Weng L; Xu Y
    Front Oncol; 2020; 10():562574. PubMed ID: 33194633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs.
    Luo R; Huang M; Wang Y
    Evid Based Complement Alternat Med; 2021; 2021():6894278. PubMed ID: 34853602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma.
    Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X
    Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
    Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.